GSRX Industries Inc () is a rapidly growing Dorado, Puerto Rico-based medical cannabis company which has fingers in many pies.
The firm is a subsidiary of Chemesis International Inc () (OTCMKTS:CADMF), a Vancouver-based vertically-integrated cannabis company, which acquired 41.6 million common shares and 1,000 preferred shares of GSRX, good for a 51% majority stake last year.
GSRX acquires, develops and operates medical cannabis dispensaries and cannabinoid (CBD) retail stores.
Currently, GSRX operates five cannabis dispensaries in Puerto Rico under the Green Spirit RX brand name. It has also signed a lease in Palm Springs for its second adult-use and medicinal cannabis dispensary in California.
GSRX is now also expanding into distribution, extraction and light manufacturing of cannabis and CBD products.
The company’s majority-owned San Francisco extraction company Spirulinex LLC is behind Dragonglass, a wildly popular all-natural dried THC powder combined with organic Spirulina.
GSRX also owns and operates the GetPureAndNatural.com e-commerce site which offers premium hemp extract products.
In its first-quarter as a Chemesis subsidiary, GSRX took in its most year-over-year quarterly revenue to date.
In a statement, Chemesis - which completed its acquisition of a majority holding in GSRX at the end of August 2019 - said GSRX earned nearly $3.5 million in revenue in its second quarter, compared to just $353.430 in the year-ago quarter.
Chemesis said GSRX also produced a gross profit of US$1.34 million and a gross margin of 39%.
The cannabis company also saw a narrowed loss of about $924,000 in the second quarter, compared to a $3.6 million loss in the prior-year quarter. It said the revenue growth was primarily achieved through its retail business in Puerto Rico, California, Texas, and Tennessee.
Point Arena facility increasing foothold in the northern California market to focus on THC manufacturing and distribution Additional licenses in Puerto Rico Offtake agreements with partners in North AmericaCommenting on an offtake agreement the firm signed with Natural Ventures in late 2019, Chemesis CEO Edgar Montero told shareholders: “Bolstering our production capability is a key element to ensure the company is able to process the increasing amount of high-CBD crops. As Puerto Rico issues more licenses, Natural Ventures will work with cultivators and provide extraction and finished good manufacturing.”
Contact Angela at [email protected]
Follow her on Twitter @AHarmantas